about
Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint ApproachInsights into the binding mode of MEK type-III inhibitors. A step towards discovering and designing allosteric kinase inhibitors across the human kinomeDetermining Cysteines Available for Covalent Inhibition Across the Human Kinome.Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology.Progress with covalent small-molecule kinase inhibitors.Overview of Current Type I/II Kinase InhibitorsStructural Insights into Characterizing Binding Sites in Epidermal Growth Factor Receptor Kinase Mutants
P50
Q24672143-C7744B60-F643-44CA-AF52-610E98690002Q33811883-850D3B13-7B37-4BFE-83F5-2D43C0D9C478Q33859476-2F19B3AB-1307-4CCC-AEEB-088869AA406DQ35926542-61EBDB42-6964-4960-8860-BEA34AFEA88CQ50033170-49EDC9B1-BF3A-48AD-ABAB-4AD37A7021CFQ59244017-0FF301EB-DA1C-4A94-A72B-59935872E0D7Q60668350-ACCA528B-3D98-4835-84CC-99DC33CC20BE
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Zheng Zhao
@ast
Zheng Zhao
@en
Zheng Zhao
@es
Zheng Zhao
@nl
Zheng Zhao
@sl
type
label
Zheng Zhao
@ast
Zheng Zhao
@en
Zheng Zhao
@es
Zheng Zhao
@nl
Zheng Zhao
@sl
prefLabel
Zheng Zhao
@ast
Zheng Zhao
@en
Zheng Zhao
@es
Zheng Zhao
@nl
Zheng Zhao
@sl
P214
P106
P21
P214
P31
P496
0000-0003-1453-3230
P7859
lccn-n97045765